Increasing use of stereotactic surgery devices for patients with various chronic conditions such as arteriovenous malformations, Parkinson’s disease, and epilepsy is a key factor driving market revenue growth.
Market Size - USD 18.57 Billion in 2020, Market Growth - CAGR of 4.0%, Market Trends - Rising investments by major players in R&D of technologically advanced products owing to growing demand for minimally invasive surgeries.
The global stereotactic surgery devices market size is expected to reach USD 25.57 Billion in 2028, and register a CAGR of 4.0% during the forecast period. Increasing adoption of minimally invasive procedures that offer various advantages such as faster recovery time, lower risk of bleeding, lower risk of pain, lower risk of infection, and smaller scars for patients undergoing surgeries with larger incisions that need removal of parts of the skull is one of the major factors expected to drive revenue growth of the global stereotactic surgery devices market.
Stereotactic surgery is a form of minimally invasive surgical technique used to treat functional defects and small tumors of the brain.
Market Size - USD 18.57 Billion in 2020, Market Growth - CAGR of 4.0%, Market Trends - Rising investments by major players in R&D of technologically advanced products owing to growing demand for minimally invasive surgeries.
The global stereotactic surgery devices market size is expected to reach USD 25.57 Billion in 2028, and register a CAGR of 4.0% during the forecast period. Increasing adoption of minimally invasive procedures that offer various advantages such as faster recovery time, lower risk of bleeding, lower risk of pain, lower risk of infection, and smaller scars for patients undergoing surgeries with larger incisions that need removal of parts of the skull is one of the major factors expected to drive revenue growth of the global stereotactic surgery devices market.
Stereotactic surgery is a form of minimally invasive surgical technique used to treat functional defects and small tumors of the brain.
Some Key Findings From the Report:
- Among the product type segments, the gamma knife segment accounted for the largest revenue share of 74.5% in the global stereotactic surgery devices market in 2020.
- North America market accounted for the largest revenue share in the global market in 2020, owing to presence of advanced healthcare facilities and increasing acceptance of new technologies in countries in the region. It has been estimated that 13,410 men and 10,410 women (23,820 adults) in the U.S. will undergo diagnosis with primary cancerous tumors related to brain and spinal cord.
- The Asia Pacific stereotactic surgery devices market size was USD 4.27 Billion in 2020, increasing medical tourism and high investments in development of advanced surgical devices by major players in the region.
- Key players profiled in the report include Elekta AB, Accuracy Inc., Ion Beam Applications SA, Mevion Medical Systems, Micromar, Inomed, Alliance Oncology, Medical AG, Monteris Medical, and Varian Medical Systems Inc. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global stereotactic surgery devices market is segmented on the basis of product type, application, end use, and region:
Product Type Outlook
- Gamma Knife
- Linear Accelerator
- Proton Beam Radiation Therapy
- Cyber Knife
Application Outlook
- Brain Tumor Treatment
- Arteriovenous Malformations Treatment
- Parkinson’s Disease Treatment
- Epilepsy Treatment
- Others
End Use Outlook
- Hospitals
- Laboratories
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Stereotactic Surgery Devices Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Stereotactic Surgery Devices Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 4. Stereotactic Surgery Devices Segmentation & Impact Analysis
Chapter 5. Stereotactic Surgery Devices Market By Product Type Insights & Trends
Chapter 6. Stereotactic Surgery Devices Market By Application Insights & Trends
Chapter 7. Stereotactic Surgery Devices Market By End-Users Insights & Trends
Chapter 8. Stereotactic Surgery Devices Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles
Companies Mentioned
- Elekta AB
- Accuracy Inc.
- Ion Beam Applications SA
- Mevion Medical Systems
- Micromar
- Inomed
- Alliance Oncology
- Medical AG
- Monteris Medical
- Varian Medical Systems Inc.
- among others
